Depletion of natural killer cells prevents allergen-induced intestinal and airway inflammation in a humanized mouse model of allergy (2019) Ose R, Weigmann B, Maxeiner J, Schuster P, Saloga J, Bellinghausen I Conference contribution Post-transcriptional regulation of Argonaute2 in malignant melanoma (2019) Linck-Paulus L, Voeller D, Meister G, Boßerhoff AK Conference contribution c-Rel is a cell cycle modulator in human melanoma cells (2019) Priebe MK, Dewert N, Amschler K, Erpenbeck L, Heinzerling L, Schoen MP, Seitz CS, Lorenz VN Journal article Differential expression of toll like receptors and antibiotic peptides by human keratinocytes (2019) Heusinger J, Herter-Kermann T, Sticherling M Conference contribution The siRNA-mediated downregulation of PD-1 alone or simultaneously with CTLA-4 shows enhanced in vitro CAR-T-cell functionality for further clinical development towards the potential use in immunotherapy of melanoma (2018) Simon B, Harrer DC, Schuler-Thurner B, Schaft N, Schuler G, Dörrie J, Uslu U Journal article CAR-T cell therapy in melanoma: A future success story? (2018) Simon B, Uslu U Journal article BRAF and MEK inhibitors change human immune cell phenotype and function; possible consequences for combination therapy (2018) Hoyer S, Eberlein V, Babalija L, Gerer K, Walter L, Schuler G, Schaft N, et al. Conference contribution The simultaneous siRNA-mediated downregulation of PD-1 and CTLA-4 to improve CAR-T cell immunotherapy of melanoma (2018) Simon B, Harrer D, Schuler-Thurner B, Dörrie J, Schaft N, Schuler G, Uslu U Conference contribution Stressed erythrocytes bind intravascular von Willebrand factor and promote microangiopathy (2018) Nicolay JP, Thorn V, Daniel C, Amann KU, Siraskar B, Lang F, Hillgruber C, et al. Conference contribution Low baseline levels of NK cells may predict a positive response to ipilimumab in melanoma therapy (2017) Tietze JK, Angelova D, Heppt MV, Ruzicka T, Berking C Journal article